Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01361893 · ClinicalTrials.gov registry record · NA

Factors Influencing the Racial Disparity in Sudden Infant Death Syndrome (SIDS)

A NA study of Sudden Infant Death Syndrome, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
616
Enrollment target
1
Study location

NCT01361893 is a NA study of Sudden Infant Death Syndrome that has completed, run by University of Virginia. The registered enrollment target is 616 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01361893, a NA study of Sudden Infant Death Syndrome, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
616 participants
Enrollment target
1
Study location

Study Summary

The overall purpose of this investigation is to better understand factors contributing to the high incidence of prone sleep positioning in African-American infants. In addition, the investigators are interested in investigating other races and ethinicities to understand their beliefs and perceptions and determine differences socioeconomically and socioculturally within and between groups. The investigators will address the following specific aims: (-) To compare knowledge, attitudes, and practices regarding infant sleep position in parents of higher and lower SES. (-) To identify risk factors for non-use of recommended supine sleep position in families with higher and lower SES (-) to develop a phenomenologic understanding of the decisions made by parents of higher SES and lower SES who do nt use recommended supine sleep position, using qualitative techniques.

Interventions

  • OTHER Lifestyle Counseling

Study Locations (1)

District of Columbia

  • Children's National Medical Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 616 participants
Start Date 2004-12
Est. Completion 2015-09
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT01361893

The ClinicalTrials.gov registry entry for NCT01361893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 616 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sudden Infant Death Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle Counseling is the first listed.

NCT01361893 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT01361893 about?

NCT01361893 is a clinical study titled "Factors Influencing the Racial Disparity in Sudden Infant Death Syndrome (SIDS)". The overall purpose of this investigation is to better understand factors contributing to the high incidence of prone sleep positioning in African-American infants. In addition, the investigators are interested in investigating other races and ethinicities to understand their beliefs and perceptions...

What is the current status of trial NCT01361893?

This trial is currently completed. It is a NA study. The enrollment target is 616 participants. The study started on 2004-12. Estimated completion is 2015-09.

What conditions does trial NCT01361893 study?

This clinical trial studies the following conditions: Sudden Infant Death Syndrome.

What interventions are being tested in trial NCT01361893?

The interventions under investigation include: Lifestyle Counseling (OTHER).

Who is sponsoring clinical trial NCT01361893?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01361893 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.